【24h】

Microbiological Screening of Platelet Concentrates in Europe

机译:欧洲血小板浓缩物的微生物筛查

获取原文
获取原文并翻译 | 示例
       

摘要

The risk of transfusion-associated sepsis due to transmission of bacteria is a persistent problem in the transfusion field. Despite numerous interventions to reduce the risk, cases of bacterial sepsis following transfusion are repeatedly being reported. Especially platelet concentrates are highly susceptible to bacterial contaminations due to the growth-promoting storage conditions. In Europe, blood establishments and national authorities have implemented individual precaution measures to mitigate the risk of bacterial transmission. To obtain an overview of the different approaches, we compiled information from national authorities, blood establishments, and the current literature. Several aspects such as the shelf life of platelets, time of sampling and the applied control measures are compared between the member states. The analysis of the data revealed a broad heterogeneity of procedures on a national level ranging from platelet release without any safety testing up to mandatory screening of all platelet concentrates prior to transfusion. Despite the substantial progress made in recent years, several bacterial reports on transfusion-associated sepsis indicate that further efforts are needed to increase the safety of blood transfusions in the long term. (c) 2019 S. Karger AG, Basel
机译:由于细菌传播导致的输血相关脓毒症的风险是输血场中的持续存在。尽管有许多干预措施来降低风险,但重复报告输血后细菌败血症病例。由于生长促进储存条件,特别是血小板浓缩物高易受细菌污染的影响。在欧洲,血型机构和国家当局实施了个人预防措施,以减轻细菌传播的风险。为了获取不同方法的概述,我们从国家当局,血液企业和当前文献中编制了信息。在成员国之间比较了几个方面,例如血小板的保质期,采样时间和所施加的控制措施。数据的分析揭示了从血小板释放的国家一级的程序的广泛的异质性,而不会在输血之前强制筛选所有血小板浓缩物的任何安全测试。尽管近年来取得了实质性进展,但有关输血相关败血症的几个细菌报告表明,需要进一步的努力来增加长期输血的安全性。 (c)2019年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号